| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NEOGENOMICS INC | Director | Common Stock | 131,023 | $1,008,877 | $7.70 | 01 Jun 2025 | Direct |
| NEOGENOMICS INC | Director | Stock Option (Right to Buy) | 16,107 | $381,134 | $43.95 | 01 Jun 2025 | Direct |
| RIGEL PHARMACEUTICALS INC | Director | Common Stock | 10,625 | $202,512 | $19.06 | 23 May 2025 | Direct |
| NEOGENOMICS INC | Director | Restricted Stock Unit | 12,254 | $192,878 | $15.74 | 01 Jun 2024 | Direct |
| CytomX Therapeutics, Inc. | Chief Medical Officer | Common Stock | 31,898 | $44,042 | $1.38 | 20 Jul 2022 | Direct |
| CytomX Therapeutics, Inc. | Chief Medical Officer | Performance Stock Units (PSUs) | 30,000 | $41,421 | $1.38 | 24 Oct 2021 | Direct |
| NEOGENOMICS INC | Director | Restricted Stock Unit | 23,077 | $0 | $15.74 | 01 Jun 2025 | Direct |
| CytomX Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 135,000 | 02 Feb 2022 | Direct | ||
| NEOGENOMICS INC | Director | Stock Options (Right to Buy) | 3,448 | 01 Jun 2025 | Direct | ||
| RIGEL PHARMACEUTICALS INC | Director | Stock Option (Right to Buy) | 3,000 | 23 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NEO | NEOGENOMICS INC | 01 Jun 2025 | 1 | $0 | 4/A | Director | 03 Jun 2025, 18:19 |
| RIGL | RIGEL PHARMACEUTICALS INC | 23 May 2025 | 2 | $0 | 4 | Director | 28 May 2025, 17:26 |
| NEO | NEOGENOMICS INC | 10 Aug 2024 | 2 | $0 | 4 | Director | 13 Aug 2024, 16:24 |
| NEO | NEOGENOMICS INC | 01 Jun 2024 | 2 | $0 | 4 | Director | 04 Jun 2024, 16:07 |
| RIGL | RIGEL PHARMACEUTICALS INC | 25 May 2024 | 2 | $0 | 4 | Director | 29 May 2024, 19:20 |
| NEO | NEOGENOMICS INC | 10 Aug 2023 | 2 | $0 | 4 | Director | 14 Aug 2023, 18:41 |
| RIGL | RIGEL PHARMACEUTICALS INC | 26 May 2023 | 2 | $0 | 4 | Director | 12 Jul 2023, 18:45 |
| CTMX | CytomX Therapeutics, Inc. | 19 Jul 2022 | 2 | -$7,965 | 4 | Chief Medical Officer | 21 Jul 2022, 16:09 |
| NEO | NEOGENOMICS INC | 10 Jun 2022 | 2 | $0 | 4 | Director | 14 Jun 2022, 20:42 |
| RIGL | RIGEL PHARMACEUTICALS INC | 20 May 2022 | 2 | $0 | 4 | Director | 23 May 2022, 17:50 |
| CTMX | CytomX Therapeutics, Inc. | 02 Feb 2022 | 2 | $0 | 4 | Chief Medical Officer | 04 Feb 2022, 15:51 |
| CTMX | CytomX Therapeutics, Inc. | 24 Oct 2021 | 2 | $0 | 4 | Chief Medical Officer | 26 Oct 2021, 16:24 |
| NEO | NEOGENOMICS INC | 02 Jun 2021 | 2 | $0 | 4 | Director | 04 Jun 2021, 20:00 |
| RIGL | RIGEL PHARMACEUTICALS INC | 19 May 2021 | 2 | $0 | 4 | Director | 21 May 2021, 21:11 |
| RIGL | RIGEL PHARMACEUTICALS INC | 14 May 2021 | 1 | $0 | 4 | Director | 18 May 2021, 19:01 |
| RIGL | RIGEL PHARMACEUTICALS INC | 14 May 2021 | 0 | $0 | 3 | Director | 18 May 2021, 18:55 |